CTOs on the Move

Wisconsin Rx

www.wisconsinrx.com

 
Wisconsin Rx is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Fitness Connection United States

At Fitness Connection, we exist to change lives every day. We are in the business because we truly believe that what we do can make the world a better place. That is why we chose to make a healthier lifestyle more accessible by providing a high-quality experience at a value.

Within Center

Within Health is a mental health care company that provides guided, introspective ketamine treatment experiences, integration and functional wellness at their clinic in Austin, Texas.

Avalon Laboratories

Avalon Laboratories is a Compton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Registered Practical Nurses Association of Ontario

Registered Practical Nurses Association of Ontario is a Mississauga, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Versartis

Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.